Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
For many users, the main goals are better blood sugar control, support with weight management, and a lower risk of diabetes-related complications when used as part of a wider care plan
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
Semaglutide mimics the naturally produced compound in the body and signals that its eaten enough
Syringe units are different
US$ 22.48
US$ 28.89
US$ 22.84
